Veteran comedian and much-loved television personality Bobby Davro, aged 67, has made a powerful and deeply personal plea for men across the United Kingdom to undergo prostate examinations after bravely disclosing his own recent prostate cancer diagnosis. Appearing on ITV’s popular morning programme, This Morning, the renowned impressionist shared his emotional journey, recounting the immense relief he felt upon receiving confirmation that his condition was not terminal. This candid revelation has ignited a vital conversation about men’s health, underscoring the critical importance of early detection and regular screening for a disease that affects a significant portion of the male population.
Davro’s public appeal specifically highlighted the Prostate-Specific Antigen (PSA) test, a straightforward blood test designed to measure a protein produced by the prostate gland. Elevated levels of PSA can indicate the presence of prostate cancer, among other prostate conditions. "I think one in eight men get it," Davro stated, emphasizing the widespread nature of the disease. He further illustrated its prevalence by sharing an encounter from his journey to the studio: "Coming in today, the man that picked me up in the car from Waterloo – he had it." His comments also drew attention to the disproportionately higher risk faced by certain demographics, noting, "I think a lot of men of colour, they get more prostate cancer, so it’s got to be checked. Get your PSA checked and have your prostate examined."
The Journey to Diagnosis and a Moment of Relief
Davro’s path to diagnosis began with a routine check-up. "My doctor told me mine was a bit swollen so I had the PSA test and it was 24, which wasn’t good at all," he explained. A normal PSA level for men typically falls below 4 ng/mL, although this can vary with age and other factors. A reading of 24 ng/mL is significantly elevated and often prompts further investigation. The subsequent care provided by the National Health Service (NHS) was exemplary, according to Davro. "The NHS have been fantastic and a couple of days later, they gave me a biopsy to check out where it is and it was intermediate," he detailed.
The term "intermediate" in prostate cancer classification generally refers to a localised cancer that has a moderate risk of progression. It implies that while the cancer is confined to the prostate, it may require active treatment rather than just monitoring. The immediate fear that grips many upon hearing a cancer diagnosis is often the question of terminality. Davro was no exception. "I asked the urologist if it’s terminal, because that’s the first thing you think of and he said no, I will be buying Christmas presents for many years to come," he recalled, tears welling up as he described the profound emotional release. "That made me cry because it was such a relief."
When asked about potential symptoms preceding his diagnosis, Davro admitted, "Not really. The only thing I had was erectile dysfunction. I can say that, can’t I?" This symptom, while not exclusive to prostate cancer, can indeed be an indicator and often prompts men to seek medical advice, potentially leading to earlier detection.
Chronology of Public Disclosure and Personal Challenges
Bobby Davro first publicly disclosed his diagnosis at the weekend during an appearance on The Andrew Eborn Show. He revealed, "I’ve got something wrong with me. I’ve got prostate cancer but I think it’s going to be alright. I think it’s sort of midrange so I’m taking all the injections and I’ve got the tablets. It’s not a nice thing to have to have." His subsequent appearance on This Morning provided a broader platform for his message, enabling him to reach a wider audience with his urgent call for men’s health awareness.
This latest health challenge for Davro comes after a period marked by significant personal adversity. Just three years prior, he endured the devastating loss of his fiancée, Vicky Wright, who bravely battled pancreatic cancer. The emotional toll of caring for a loved one with cancer and then losing them can be immense, and Davro’s resilience in the face of his own diagnosis is particularly poignant. Furthermore, Davro also suffered a stroke two years ago, a health event from which he appears to have largely recovered, telling Eborn at the time, "I think I’m alright now." These successive health battles underscore Davro’s determination and his willingness to use his public platform to shed light on important health issues.
Understanding Prostate Cancer: Prevalence, Risk Factors, and Screening
Prostate cancer is the most common cancer among men in the UK, with over 52,000 new cases diagnosed each year. Tragically, more than 12,000 men die from the disease annually. These statistics highlight the critical need for increased awareness and proactive screening.
Key Risk Factors:
- Age: The risk significantly increases with age, with most cases diagnosed in men over 50.
- Family History: Men with a father or brother who had prostate cancer before age 60 are at higher risk. The risk increases further if more than one close relative was affected.
- Ethnicity: As Davro rightly pointed out, Black men have a higher risk of developing prostate cancer than white men. They are also more likely to develop it at a younger age and to develop an aggressive form of the disease. This disparity is a significant area of ongoing research and public health focus.
- Diet: While research is ongoing, some studies suggest a diet high in red meat or dairy products may slightly increase risk, while a diet rich in fruits, vegetables, and fish may be protective.
Symptoms to Watch For:
In its early stages, prostate cancer often presents no symptoms, which is why screening is so vital. When symptoms do occur, they can include:
- Difficulty starting to urinate or a weak, interrupted flow.
- Frequent urination, especially at night.
- Pain or burning during urination.
- Blood in the urine or semen.
- Erectile dysfunction (as experienced by Davro).
- Pain in the back, hips, or pelvis (often indicating advanced disease).
The Role of the PSA Test:
The PSA test measures the level of prostate-specific antigen in the blood. While a valuable tool, it’s not without its limitations.
- False Positives: Elevated PSA levels can be caused by conditions other than cancer, such as benign prostatic hyperplasia (BPH – an enlarged prostate), prostate infection (prostatitis), or even vigorous exercise.
- False Negatives: Some men with prostate cancer may have normal PSA levels.
- Overdiagnosis: The PSA test can detect slow-growing cancers that might never cause harm during a man’s lifetime. Treating these cancers can lead to unnecessary side effects from treatment.
Despite these nuances, the PSA test remains a crucial first step in screening, often followed by a Digital Rectal Examination (DRE) where a doctor manually checks the prostate for abnormalities. If either test raises concerns, further diagnostic tests like an MRI scan or a biopsy are typically recommended to confirm a diagnosis and determine the cancer’s aggressiveness.
NHS Guidelines and Public Health Advocacy
The NHS does not operate a national screening programme for prostate cancer due to the complexities surrounding the PSA test. Instead, it offers "informed choice" screening for men over 50 who request it, following a discussion with their GP about the pros and cons. This approach aims to empower men to make an educated decision about their health, weighing the potential benefits of early detection against the risks of overdiagnosis and overtreatment.
Organisations like Prostate Cancer UK tirelessly advocate for greater awareness and improved diagnostic methods. They consistently highlight the disparities in risk among different ethnic groups and campaign for better support services for men living with and beyond prostate cancer. Davro’s personal story serves as a powerful testament to their ongoing efforts.
The "Celebrity Effect" and Broader Implications
Bobby Davro’s public disclosure is not an isolated incident. Over the years, numerous high-profile figures have spoken out about their battles with prostate cancer, significantly impacting public awareness and encouraging men to get checked. Notable examples include Stephen Fry, who revealed his diagnosis in 2018, and BBC presenter Bill Turnbull, whose courageous sharing of his advanced prostate cancer journey before his passing in 2022 led to a significant surge in men seeking PSA tests – a phenomenon dubbed the "Bill Turnbull effect." Singer Rod Stewart has also been a vocal advocate for prostate cancer awareness following his own diagnosis.
Such celebrity endorsements play a critical role in demystifying the disease, reducing the stigma associated with discussing men’s health issues, and prompting actionable responses from the public. When a familiar face shares such a personal struggle, it resonates more deeply with individuals, making the abstract threat of cancer feel more tangible and the call to action more urgent.
Davro’s openness has the potential to create a similar "Davro effect," prompting countless men, particularly those in the high-risk categories he mentioned, to consider getting tested. This increased awareness is crucial, as early detection significantly improves treatment outcomes and overall survival rates for prostate cancer.
Conclusion: A Call to Action for Men’s Health
Bobby Davro’s courageous decision to share his prostate cancer diagnosis extends beyond a mere personal revelation; it is a profound act of public service. By candidly discussing his symptoms, the diagnostic process, and his emotional response to the news, he has shone a much-needed spotlight on a disease that often lurks silently. His message is clear and unequivocal: men must take proactive steps to safeguard their prostate health, starting with a conversation with their doctor about the PSA test and a prostate examination.
The comedian’s journey, marked by previous personal tragedies and health scares, underscores the unpredictable nature of life and the importance of vigilance. His willingness to speak out, even in the face of personal vulnerability, empowers others to overcome apprehension and prioritise their well-being. Ultimately, Davro’s story serves as a potent reminder that while a cancer diagnosis can be terrifying, early detection offers the best hope for a positive outcome, allowing men like him to look forward to "buying Christmas presents for many years to come." His advocacy stands as a powerful testament to the ongoing fight against prostate cancer and a vital call to action for men everywhere.
